Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma
Status:
Completed
Trial end date:
2018-02-21
Target enrollment:
Participant gender:
Summary
The multicenter real-world and propensity score matching comparative study was designed to
explore the toxicity and effectiveness of Lobaplation or Cisplatin based adjuvant
chemotherapy in esophageal carcinoma